Sequoia Financial Advisors LLC purchased a new stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 7,406 shares of the electronics maker’s stock, valued at approximately $550,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Securian Asset Management Inc. increased its stake in Dolby Laboratories by 3.0% during the 1st quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker’s stock valued at $373,000 after purchasing an additional 137 shares in the last quarter. MAI Capital Management increased its stake in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after purchasing an additional 162 shares in the last quarter. US Bancorp DE increased its stake in Dolby Laboratories by 18.6% during the 1st quarter. US Bancorp DE now owns 1,444 shares of the electronics maker’s stock valued at $116,000 after purchasing an additional 226 shares in the last quarter. Linden Thomas Advisory Services LLC increased its stake in Dolby Laboratories by 2.7% during the 1st quarter. Linden Thomas Advisory Services LLC now owns 8,635 shares of the electronics maker’s stock valued at $693,000 after purchasing an additional 229 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. increased its stake in Dolby Laboratories by 2.2% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 10,911 shares of the electronics maker’s stock valued at $876,000 after purchasing an additional 235 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.
Dolby Laboratories Stock Up 0.9%
Shares of DLB stock opened at $68.79 on Monday. The company has a 50 day moving average price of $71.85 and a 200-day moving average price of $73.63. Dolby Laboratories has a 52 week low of $67.54 and a 52 week high of $89.66. The firm has a market capitalization of $6.59 billion, a PE ratio of 25.20 and a beta of 0.92.
Dolby Laboratories Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were issued a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.9%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.35%.
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Dolby Laboratories in a research note on Wednesday, October 8th. Rosenblatt Securities restated a “buy” rating and set a $95.00 price objective on shares of Dolby Laboratories in a research note on Friday, August 1st. Tigress Financial raised their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research note on Friday, August 15th. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Finally, Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target for the company. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $95.75.
Read Our Latest Analysis on DLB
Insider Buying and Selling
In related news, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total value of $524,440.00. Following the transaction, the senior vice president owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $72.31, for a total transaction of $1,807,750.00. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $8,295,764.75. The trade was a 17.89% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 82,000 shares of company stock worth $5,845,440. 38.39% of the stock is currently owned by insiders.
Dolby Laboratories Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also
- Five stocks we like better than Dolby Laboratories
- Most Volatile Stocks, What Investors Need to Know
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- How to Choose Top Rated Stocks
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- How to Find Undervalued Stocks
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.